InMed Pharmaceuticals (NASDAQ:INM) Applies To Conduct Phase 2 Clinical Studies Of INM -755 Cream To Treat EB In Israel, Australia, And Serbia
InMed Pharmaceuticals (NASDAQ:INM) seeks the permission of local authorities in Israel, Australia, and Serbia to conduct phase 2 clinical studies
Read more